HOME >> BIOLOGY >> NEWS
Understanding IGF-1: Jefferson researcher sees drug potential in targeting enzyme

Pharmaceutical companies around the world still come knocking on Renato Baserga, M.D.,'s door.

And for good reason.

He has labored for years over trying to understand and detail the behavior of insulin-like growth factor-1 (IGF-1) receptor, a protein which plays an important role in tumor growth. Several years ago he and his co-workers discovered that normal cells lacking the IGF-1 receptor gene could not be made to turn cancerous. He found that when they "knocked out" IGF-1 receptors in cancer cells, the cells self-destructed, meaning the IGF-1 receptor was somehow necessary for tumor cell growth. Companies are interested in targeting the IGF-1 receptor with the idea of killing cancer cells, he says.

According to Dr. Baserga, who is professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and acting director of Jefferson's Kimmel Cancer Center, in the past few years, scientists have learned that the IGF-1 receptor is also a key growth factor that regulates cell and body size. Deleting the genes for the IGF-1 receptor and its docking protein IRS-1 result in mouse and fly embryos that are only 50 percent of normal size.

"This tells you in essence that the IGF-1 receptor and its docking protein control 50 percent of body size in a non-redundant way," he says. "This was an important finding because it established the role of IGF-1 receptor and IRS-1 in controlling body size."

Reporting August 19, 2005 in the Journal of Biological Chemistry, Dr. Baserga and his co-workers provide one possible molecular explanation for how this occurs.

They found that when IRS-1 is activated with the IGF-1 receptor, -catenin, a protein important in colon and breast cancer is turned on. "We're the first ones to discover that IRS-1 goes to the cell nucleus, where it binds a protein, -catenin, in the nucleus that regulates RNA polymerase 1, the enzyme that controls cell size," he ex
'"/>


20-Sep-2005


Page: 1 2

Related biology news :

1. Understanding why C. difficile causes disease -- its hungry
2. Understanding the global carbon budget -- Woods Hole Research Center expert provides insights
3. Understanding occupational safety and health issues of nanotechnology
4. Understanding the Arctic -- NSF-funded expeditions cover new ground in climate science
5. Understanding climate change: Public forum in Philadelphia next week
6. Understanding food nutrition labels challenging for many people
7. Understanding of cell protection mechanism points to therapies to prevent heart attacks and strokes
8. Understanding the life of C. elegans
9. Drawing a crowd: Understanding the signals that bring inflammatory cells into the lung
10. Jane Lubchenco receives the 2005 AAAS Public Understanding of Science and Technology Award
11. Understanding the oceans microbes is key to the Earths future

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... , ... KICVentures announced today its plans to host an event ... ASC Conference in Chicago on Thursday, June 13th at 6:30 pm. The event will ... the 3rd floor Ticino Hospitality room in space #74T. , The event will feature ...
(Date:6/6/2019)... (PRWEB) , ... June 05, 2019 , ... ... top companies and solutions in the global health and medical technology market, announced ... its “Best Healthcare Navigation / Robotics Solution” award in the 2019 MedTech Breakthrough ...
(Date:6/4/2019)... (PRWEB) , ... June 04, 2019 , ... ... today announced the appointment of Susan Murphy as the new President of Molecular ... Sciences?owned by Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... 2019 , ... Alice Branton today released research results from preclinical trials on ... which can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... crystallite size , Over 142% increase in particle size , ...
(Date:6/12/2019)... TOWNSHIP, N.J. (PRWEB) , ... June 12, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... with Shanghai Zillion has been signed. The agreement will grant exclusive rights for ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 10, 2019 , ... ... today announced IOPP will add 80 of its scientific journals to DeepDyve’s rental ... physics-related content to DeepDyve’s continually expanding library of more than 20 million articles, ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study released today ... (MSC-EV) are able to incorporate into human CD34+ cells, modifying their gene expression ... also increased the cells’ ability to lodge into bone marrow. This research performed ...
Breaking Biology Technology:
Cached News: